Bioreductive prodrugs for cancer therapy.
Seddon
Beatrice
B
Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, UK.
Kelland
Lloyd R
LR
Workman
Paul
P
D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000633:toxicity; D001711:Biotransformation; D015687:Cell Hypoxia / Q000187:drug effects; D002986:Clinical Trials as Topic; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010084:Oxidation-Reduction; D011355:Prodrugs / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011355:Prodrugs